Our top pick for
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Thanks to massive government efforts worldwide, we now have several approved vaccines. Aside from protecting your health, a coronavirus vaccine can help you earn some money if you invest in the right company.
As of September 2021, there are eight either fully approved vaccines or approved for emergency use by the WHO or governments worldwide. These vaccines are made by the companies:
Yes. As long as the company developing the vaccine is a publicly-traded entity, investors can back as many COVID-19 vaccine candidates as they like.
As far as stock performance goes, many have seen staggering success. Maryland-based firm NovaVax has seen its stock price rise more than 6,000% from January 2020, while Moderna has risen over 2,000%.
AstraZeneca is a British-Swedish pharmaceutical company headquartered in Cambridge, England. It partnered with Oxford University to create the Vaxzevria vaccine, which was first authorized for emergency use in the UK and Argentina in December 2020.
Sinovac Biotech is a Chinese biotechnology company headquartered in Beijing. Its vaccine, the CoronaVac, was given a conditional approval in China in February 2021.
Pfizer Inc is a US pharmaceutical company. It has partnered with German biotech company BioNTech to create and manufacture a COVID vaccine. Their vaccine is approved by the FDA for those 16 or older, and it has an emergency authorization for those who are between 12 and 15 years old.
Sinopharm Group is a Chinese pharmaceuticals company currently trialing two vaccine candidates in partnership with the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products. Both vaccines are approved for emergency use in many countries, while only one of the vaccines is approved for emergency use by the WHO.
Moderna is a Boston-based biotechnology company. The US government supported the company with almost $1 billion to accelerate the development of a coronavirus vaccine in partnership with the National Institute of Allergy and Infectious Diseases. In December 2020, FDA gave the vaccine an emergency use authorization, but now the company has filed for a full FDA approval for those 18 or older.
CanSino Biologics is a Chinese vaccine maker working in partnership with the Academy of Military Medical Sciences. Unlike many other vaccines, this one requires only one shot.
American pharmaceutical corporation Johnson & Johnson is the parent company of Janssen Vaccines & Prevention. Janssen received an emergency authorization by the FDA in February 2021.
Novavax is a US vaccine development firm headquartered in Maryland. It started Phase 3 human trials in the UK in mid-September. The Chief executive of Novavax expects an emergency use approval by the FDA in the fourth quarter of 2021.
BioNTech is a German biotechnology company. It has partnered with Chinese pharmaceutical firm Fosun Pharma and US pharmaceutical company Pfizer to trial and manufacture a vaccine candidate.
Fosun Pharma is a Chinese pharmaceutical firm. It has partnered with German biotech company BioNTech and US pharmaceutical company Pfizer to trial and manufacture a vaccine candidate.
A number of the listed companies working on a COVID-19 cure are from countries outside the US. And most US brokerages only offer access to domestic stock exchanges, like the NYSE and NASDAQ.
That said, some international companies dual-list in the US, like AstraZeneca and Sinovac Biotech. Both can be accessed on the NASDAQ.
But if you’d like to invest in any of the others, be prepared to open an international brokerage account with a platform that offers access to global markets, like Charles Schwab, Fidelity or Interactive Brokers. These brokerages can connect you to overseas exchanges, but consider the platform’s fees and exchange rates before you apply.
We compare two of the largest crypto exchanges in the world to see how they stack up.
Explore all of the ways to earn interest on a variety of cryptocurrency assets by using KuCoin exchange, including staking and lending.
Learn how to earn interest on your cryptocurrency using Coinbase exchange. Finder’s guide to earning on Coinbase has information on Coinbase Learn, staking and DeFi.
An investment platform that lets you buy and sell fractional shares of culturally significant items.
Features, costs and ratings to consider before you open an account.
A digital account that prioritizes your access to your money and is light on fees.
The Terra Virtua marketplace is a platform focused on the entertainment industry and is for users looking to interact with NFTs and immerse themselves in augmented and virtual reality.
Your complete guide to buying and selling NFTs (non-fungible tokens) on popular marketplace Nifty Gateway
An app-focused bank that offers competitive savings rates, minimal fees and a goal-oriented approach to managing money.
CD terms from 3 months to 5 years and no monthly fees but a minimum balance is required.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.